Hu, X., Zhang, Q., Sun, T., Yin, Y., Li, H., Yan, M., . . . Hao, X. Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2− advanced breast cancer: Final results of the randomized phase III MONARCH plus trial. Wolters Kluwer.
Chicago Style (17th ed.) CitationHu, Xichun, et al. Abemaciclib Plus Non-steroidal Aromatase Inhibitor or Fulvestrant in Women with HR+/HER2− Advanced Breast Cancer: Final Results of the Randomized Phase III MONARCH Plus Trial. Wolters Kluwer.
MLA (9th ed.) CitationHu, Xichun, et al. Abemaciclib Plus Non-steroidal Aromatase Inhibitor or Fulvestrant in Women with HR+/HER2− Advanced Breast Cancer: Final Results of the Randomized Phase III MONARCH Plus Trial. Wolters Kluwer.
Warning: These citations may not always be 100% accurate.